The Met Signaling Pathway and Cancer

MET｜Popular Gene Target of Lung Cancer ResearchПодробнее

Signaling Pathways in Cancer Symposium: Michael CombПодробнее

Impaired c-Met Receptor Degradation Mediated by MET Exon 14 Mutations in Non–Small-Cell Lung CancerПодробнее

Oncotarget | CCL20 and Signaling Pathways in Colorectal CancerПодробнее

MET Signaling in NSCLC: Challenges and opportunities for biomarker development and drug discoveryПодробнее

Signaling Pathways in Cancer Symposium: Jeff SettlemanПодробнее

Signaling Pathways in Cancer Symposium: Joan BruggeПодробнее

The Hedgehog Signaling Pathway and CancerПодробнее

Targeting HER2, BRAF, KRAS, METПодробнее

Signaling Pathways in Cancer Symposium: Rudolf JaenischПодробнее

Novel therapies beyond immunotherapy for GI MalignanciesПодробнее

Early Clinical Trials in HGF/C-MET Targeted Therapy - Dr. Johanna Bendell, Dr. David SpigelПодробнее